Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelly Joseph-Mathurin

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Nature Medicine|February 10, 2025
Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementiaJorge J Llibre-Guerra, M Victoria Fernandez, Nelly Joseph-Mathurin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumNelly Joseph-Mathurin, Charles D Chen, Diana A Hobbs, et al.
Acta Neuropathologica|July 28, 2021
Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer diseaseCharles D Chen, Nelly Joseph-Mathurin, Namita Sinha, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2022
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Neurobiology of Disease|March 31, 2022
CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer diseaseJeremy F Strain, Nicolas Barthelemy, Kanta Horie, et al.
The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.
Research Square|November 24, 2025
The Knight Alzheimer Research Imaging (KARI) dataset: a comprehensive multimodal resource for exploring aging, preclinical, and symptomatic Alzheimer disease pathologyDavid A Hoagey, Nicole S McKay, Nelly Joseph-Mathurin, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 13, 2018
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's diseaseNelly Joseph-Mathurin, Yi Su, Tyler M Blazey, et al.
Human Brain Mapping|October 23, 2023
T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer diseaseFarzaneh Rahmani, Matthew R Brier, Brian A Gordon, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Systematic proteomics in Autosomal dominant Alzheimer's disease reveals decades-early changes of CSF proteins in neuronal death, and immune pathwaysYuanyuan Shen, Muhammad Ali, Jigyasha Timsina, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Nature Medicine|February 10, 2025
Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementiaJorge J Llibre-Guerra, M Victoria Fernandez, Nelly Joseph-Mathurin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumNelly Joseph-Mathurin, Charles D Chen, Diana A Hobbs, et al.
Acta Neuropathologica|July 28, 2021
Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer diseaseCharles D Chen, Nelly Joseph-Mathurin, Namita Sinha, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2022
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Neurobiology of Disease|March 31, 2022
CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer diseaseJeremy F Strain, Nicolas Barthelemy, Kanta Horie, et al.
The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.
Research Square|November 24, 2025
The Knight Alzheimer Research Imaging (KARI) dataset: a comprehensive multimodal resource for exploring aging, preclinical, and symptomatic Alzheimer disease pathologyDavid A Hoagey, Nicole S McKay, Nelly Joseph-Mathurin, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 13, 2018
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's diseaseNelly Joseph-Mathurin, Yi Su, Tyler M Blazey, et al.
Human Brain Mapping|October 23, 2023
T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer diseaseFarzaneh Rahmani, Matthew R Brier, Brian A Gordon, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
Systematic proteomics in Autosomal dominant Alzheimer's disease reveals decades-early changes of CSF proteins in neuronal death, and immune pathwaysYuanyuan Shen, Muhammad Ali, Jigyasha Timsina, et al.
Pageof 6